NASDAQIndustrialsConglomeratesSnapshot 2026-10-23
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Negative cash flow from operations improves toward break-even | Cash flow from operations improved but remains negative at -$2.75M. | Intact | cash flow from operations worsens beyond -$2.75M next quarter | Cash from operations: $2.405M FY2026-Q2; GAAP. Published target: negative cash flow from operations > -$2.75M next quarter. The target does not explicitly identify fiscal versus calendar quarters. Source published Aug 13, 20262,405,000 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 3 of last 3 quarters. Cash from operating activities improved from negative $4.3 million in 2025-Q4 to negative $2.7 million in 2026-Q1 but worsened to negative $3.5 million in 2026-Q2. The trajectory shows mixed progress with ongoing negative cash flow. Delivery assessment Oct 24, 2026 |
Net income turns positive and sustains | Net income rose from -$0.296M to $3.07M, showing progress toward profitability. | Intact | net income falls below $0 in next quarter | Net income: $-160,000 FY2026-Q2; GAAP. Published target: >= $3.07M net income next quarter. The target does not explicitly identify fiscal versus calendar quarters. Source published Aug 13, 2026-160,000 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 7d65d408-a1a0-4c0d-a1a3-d1d97f1d794e. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 3 of last 3 quarters. Operating income improved from negative $2.0 million in 2025-Q4 to positive $6.5 million in 2026-Q1, net income improved similarly. However, Q2 2026 saw a consolidated net loss of $0.3 million and Adjusted EBITDA loss of $5.2 million, indicating mixed profitability trajectory with some volatility. Delivery assessment Oct 24, 2026 |
Operating income improves to positive territory | Falcon's Beyond Global improved operating income from -$2.04M to $6.49M in one quarter. | Intact | operating income falls below $0 in next quarter | Operating income: $-262,000 FY2026-Q2; GAAP. Published target: >= $6.49M operating income next quarter. The target does not explicitly identify fiscal versus calendar quarters. Source published Aug 13, 2026-262,000 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 7d65d408-a1a0-4c0d-a1a3-d1d97f1d794e. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 3 of last 3 quarters. Operating income improved from negative $2.0 million in 2025-Q4 to positive $6.5 million in 2026-Q1, net income improved similarly. However, Q2 2026 saw a consolidated net loss of $0.3 million and Adjusted EBITDA loss of $5.2 million, indicating mixed profitability trajectory with some volatility. Delivery assessment Oct 24, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Sep 25–Oct 24 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 13, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This investment represents a speculative growth opportunity. The current thesis is cautious, given the mixed financial performance and high valuation compared to peers.
The market seems to have priced in an expensive valuation, reflecting a premium of nearly 10% compared to its peers. This high valuation is supported by the company's optionality but is tempered by its weak execution quality.
Management has set ambitious goals, like doubling revenues in its FCG division, but progress has been limited. Recent financial results show volatility, with mixed profitability and ongoing negative cash flow, indicating uncertainty in the near term.
The future of FBYD hinges on its ability to meet management's revenue goals and improve profitability. Additionally, the performance of sector leaders like MMM, HON, and VMI will be crucial, as their results can significantly impact sentiment and momentum in the Industrials sector.
Over the next 1 to 3 years, FBYD's performance will depend on its execution and broader sector trends. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.